These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27389078)

  • 1. Complication in diabetic nephropathy.
    John S
    Diabetes Metab Syndr; 2016; 10(4):247-249. PubMed ID: 27389078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiovascular protection of diabetic patient with chronic renal disease and particular case of end-stage renal disease in elderly patients].
    Zaoui P; Hannedouche T; Combe C
    Nephrol Ther; 2017 Jun; 13(6S):6S16-6S24. PubMed ID: 29463395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Losartan in diabetic nephropathy.
    Perico N; Ruggenenti P; Remuzzi G
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic nephropathy.
    Kobrin SM
    Dis Mon; 1998 May; 44(5):214-34. PubMed ID: 9656970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
    Crook ED; Preddie DC
    Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current issues in the diagnosis and therapy of diabetic nephropathy].
    de Châtel R; Mogyorósi A; Ziyadeh FN
    Orv Hetil; 1997 Jan; 138(4):187-93. PubMed ID: 9072751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rate of progression of type 2 diabetes mellitus to end stage renal disease - A single centred retrospective study from Malaysia.
    Ng YP; Ahmed R; Ooi GS; Lau CY; Balasubramanian GP; Yap CH
    Diabetes Metab Syndr; 2018 Nov; 12(6):1025-1030. PubMed ID: 30168425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic nephropathy.
    Lapuz MH
    Med Clin North Am; 1997 May; 81(3):679-88. PubMed ID: 9167651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreas transplantation for the prevention of diabetic nephropathy.
    Stegall MD; Larson TS; Kudva YC; Grande JP; Nyberg SL; Prieto M; Velosa JA; Rizza RA
    Mayo Clin Proc; 2000 Jan; 75(1):49-56. PubMed ID: 10630757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common Drugs for Stabilization of Renal Function in the Progression of Diabetic Nephropathy and Their Relations with Hypertension Therapy.
    Wang Y; Wang C; Zhang X; Gu HF; Wu L
    Curr Diabetes Rev; 2018; 14(2):149-161. PubMed ID: 28201968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin A receptor antagonists in diabetic kidney disease.
    Georgianos PI; Agarwal R
    Curr Opin Nephrol Hypertens; 2017 Sep; 26(5):338-344. PubMed ID: 28520568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The increasing prevalence of diabetic nephropathy as a cause of end stage renal disease in Nigeria.
    Alebiosu CO; Ayodele OE
    Trop Doct; 2006 Oct; 36(4):218-9. PubMed ID: 17034695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel effective drugs for diabetic kidney disease? or not?
    Gentile G; Mastroluca D; Ruggenenti P; Remuzzi G
    Expert Opin Emerg Drugs; 2014 Dec; 19(4):571-601. PubMed ID: 25376947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The diabetic patient: renal insufficiency like other kidney failures?].
    Rossert J
    Nephrol Ther; 2006 May; 2 Suppl 3():S187-9. PubMed ID: 17370848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
    Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
    Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic nephropathy as a cause of end-stage renal disease in Egypt: a six-year study.
    Afifi A; El Setouhy M; El Sharkawy M; Ali M; Ahmed H; El-Menshawy O; Masoud W
    East Mediterr Health J; 2004; 10(4-5):620-6. PubMed ID: 16335654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of (pro)renin receptor in human kidneys with end-stage kidney disease due to diabetic nephropathy.
    Takahashi K; Yamamoto H; Hirose T; Hiraishi K; Shoji I; Shibasaki A; Kato I; Kaneko K; Sasano H; Satoh F; Totsune K
    Peptides; 2010 Jul; 31(7):1405-8. PubMed ID: 20385187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.